- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC in the Press, August 19, 2016
A review of coverage of our peer-reviewed research, in the mainstream and healthcare press.
Two articles in the new issue of The American Journal of Managed Care are gaining notice in the healthcare press this week. David Salazar of DrugStore News was among those who wrote about “The Impact of Formulary Drug Exclusion Policies on Patients and Heatlhcare Costs,” which is a review 26 studies. The article, by researchers at the Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies, in the Center for the Evaluation of Value and Risk in Health, found that while there are exceptions, most research shows that exclusions save money without harming patients.
The article, “Opinions on the Hospital Readmission Reduction Program: Results of a National Survey of Hospital Leaders,” drew plenty of reader and press interest. Jacqueline Belliveau of RevenueCycle Intelligence covered the results of the survey, which found that two-thirds of respondents feel CMS’ financial penalties for not meeting 30-day readmission targets are having a major effect on their efforts to decrease readmissions. The authors, from Harvard’s T.H. Chan School of Public Health, also found that three-quarter of the leaders faulted CMS for failing to account for differences in the socioeconomic mix of hospital populations.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
